EP-1174 Assessment of nausea and dysgeusia in head and neck cancer patients undergoing radiotherapy

Caterina Iorio, Umberto Ricardi(Azienda Ospedaliero Universitaria San Giovanni Battista), Francesca Arcadipane, E. Olimpio, Salvatore Martini(University of Campania "Luigi Vanvitelli"), P. Franco

Radiotherapy and Oncology

April 1, 2019

10.1016/s0167-8140(19)31594-4

Cited by 0

Related Papers

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

|The Lancet Oncology|2020|1.1k

Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document

|Radiotherapy and Oncology|2020|646

An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer

|Clinical Lung Cancer|2014|437

SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease

|Neuro-Oncology|2013|371

Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial

|Lung Cancer|2009|277